Hasil Pencarian
Ditemukan 1612 dokumen dengan kata kunci 4049 Simpan CSV Simpan CSV
Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensivedisease- small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial
No. Panggil: Annals of Oncology; Volume 24, No.1, January 2013, p.75-83 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer
No. Panggil: Annals of Oncology; Volume 24, No.2, February,2013,p.314-321 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
No. Panggil: Annals of Oncology; Volume 24, No.1, January 2013, p54-59 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human am integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer
No. Panggil: Annals of Oncology; Volume 24, No.2, February,2013,p.329-336 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG
No. Panggil: Annals of Oncology; Volume 24, No.3, Maret, 2013, p.679-687 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1813-1821 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Predictors of immunological failure and determinants of suboptimal CD4 testing among adults with HIV on first-line antiretroviral therapy in Andhra Pradesh, India, 2008–2011
No. Panggil: Transactions of The Royal Society of Tropical Medicine and Hygiene;Volume 109 No.5 Mei 2015 p 325–333 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)
No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1615-1622 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group
No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1580-1587 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study
No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1560-1567 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Prev   1 2 3 4 5 6 7 8 9 10  Next